Papaverine, Solution for Injection, 20 Mg/Ml, 2 Ml Tender - 140482492

Procurement Summary

Country: Ukraine

Summary: Papaverine, Solution for Injection, 20 Mg/Ml, 2 Ml Each; Drotaverin Solution for Injections 20 Mg/Ml, 2 Ml in an Ampoule; Drotaverin Tablets 40 Mg; Activated Charcoal Tablets/Capsules of 250 Mg; Human Insulin (...

Deadline: 02 May 2026

Posting Date: 01 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 140482492

Document Ref. No.: UA-2026-04-29-012162-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 32625.37

CPV Classification

33600000 - Pharmaceutical products
33610000 - Medicinal products for the alimentary tract and metabolism

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Papaverine, solution for injection, 20 mg/ml, 2 ml each; Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule; Drotaverin tablets 40 mg; Activated charcoal tablets/capsules of 250 mg; Human insulin (short-acting), solution for injection, 100 U/ml, bottle, 10 ml each; Calcium gluconate solution for injection 100 mg/ml in 5 ml; Salts for oral rehydration, powder for oral solution, 18.9 g each; Ascorbic acid solution for injection, 100 mg/ml in 2 ml; Heparin sodium, solution for injection, 5000 IU/ml, 5 ml each; Aminocaproic acid, solution for infusions, 50 mg/ml, 100 ml each; Ethamsylate solution for injection, 125 mg/ml in 2 ml; Glucose solution for injections 40% in 20 ml; Glucose solution for infusions 5% in 500 ml (PE container/bottle); Sodium chloride, solution for infusion, 9 mg/ml 200 ml; Sodium chloride, solution for injection, 9 mg/ml, 5 ml each; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Electrolytes in combination with Sorbitol 60 mg/1 ml solution for infusions of 200 ml; Trisol solution for infusions of 200 ml; sodium bicarbonate solution for infusions 40 mg/ml 100 ml; Epinephrine 1.82 mg/ml, solution for injection, ampoule; Isosorbide, tablets, 10 mg each; Validol tablets 60 mg each; Sodium heparin, gel, 1000 IU/g, 50 g each; Captopril/hydrochlorothiazide, tablets, 50/25 mg each; Dexpanthenol foam for the skin 50 mg/g per 116 g; Chloramphenicol/methyluracil ointment 7.5 mg/40 mg per 40 g; Chlorhexidine, solution for external use 0.05% per 100 ml; Hydrogen peroxide, solution, 3%, 40 ml each; Diamond... Type of purchase: goods Classifier and its relevant code: DC 021:2015: 33600000-6 — Pharmaceutical products Etamsylate solution for injection, 125 mg/ml in 2 ml; Classification according to INN: Glucose, Dose of active substance: 50 mg/ml, Release form: Solution for infusion, Volume: 500, Type of packaging: Container, Bottle, Classification according to ATX: B05CX01; Classification according to ATX: D08AC02, INN: Chlorhexidin...

Documents

 Tender Notice